Performance of plasma measurement of neutrophil gelatinase-associated lipocalin as a biomarker of bacterial infections in the intensive care unit
Authors:
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Journal of Critical Care
- Vol. 53, 264-270
Abstract
No abstract availableKeywords
Funding Information
- Stockholms Läns Landsting
This publication has 29 references indexed in Scilit:
- Interpretation of C-Reactive Protein Concentrations in Critically Ill PatientsBioMed Research International, 2013
- The Origin of Multiple Molecular Forms in Urine of HNL/NGALClinical Journal of the American Society of Nephrology, 2010
- Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for SepsisAntimicrobial Agents and Chemotherapy, 2010
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trialThe Lancet, 2010
- Benefit of Appropriate Empirical Antibiotic Treatment: Thirty-day Mortality and Duration of Hospital StayThe American Journal of Medicine, 2006
- Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: A study of the kineticsActa Paediatrica, 2005
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceIntensive Care Medicine, 2003
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infectionsScandinavian Journal of Clinical and Laboratory Investigation, 1995
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992